摘要
目的:分析星形奴卡菌的临床感染和对抗生素的耐药性,指导临床治疗。方法:对2000年7月～2010年5月从临床分离的星形奴卡菌的临床分布特点,伴随的原发疾病及耐药情况进行回顾分析。结果:星形奴卡菌主要引起呼吸道感染,这种感染常伴随多种原发的基础性疾病,磺胺类药物是治疗星形奴卡菌感染的首选用药。结论:监测本地区星形奴卡菌对药物,特别对磺胺类药物的耐药性,根据药敏试验针对性选用抗菌药物,为临床治疗提供指导意见。
Objective：To analyze the star of clinical Nocardia infection and antibiotic resistance in clinical treatment.Methods：From July 2000 to May 2010 clinical isolates of the star from Nocardia clinical distribution,with the primary disease and drug resistance were analyzed retrospectively.Results：The primary star caused by Nocardia respiratory infection,the infection is often associated with the basis for a variety of primary disease,sulfa drugs to treat star Nocardia in fection drug of choice.Conclusion：Monitoring the region Nocardia star drug,especially sulfa drug resistance,according to targeted use of antimicrobial drugs susceptibility test,provide guidance for clinical treatment.
出处
《中国当代医药》
2010年第30期68-69,共2页
China Modern Medicine
关键词
星形奴卡菌
耐药性
临床感染
Star Nocardia
Drug resistance
Clinical infection
